Bookmark
Forward
Explore Curated Studies Results
Explore Literature Results
Explore Clinical Trials Results
QuickView for ErbB 3 (compound)
Most Correlated Studies
- Liver tumors from Erbb2-transformed (BDEneu) or spontaneous-transformed (BDEsp) cholangiocytes
- Breast adenocarcinoma MDA-MB-361 cells depleted of DCD
- Breast invasive ductal carcinoma ZR-75-30 cells with CDK12 overexpression
- Uteri of ovariectomized Ncoa2 (SRC-2) knockout mice treated with progesterone
Most Relevant Literature
- A recombinant affitoxin derived from a HER3 affibody and diphteria-toxin has potent and selective an…
- Switchable DNA Catalysts for Proximity Labeling at Sites of Protein-Protein Interactions.
- HER3 PET Imaging Predicts Response to Pan Receptor Tyrosine Kinase Inhibition Therapy in Gastric Can…
- HER3 receptor and its role in the therapeutic management of metastatic breast cancer.
- Nanoplatform-based analysis for the detection of HER3 and HER4 for gastric cancer diagnosis.
Most Relevant Clinical Trials
- A Study of BDTX-189, an Orally Available Allosteric ErbB Inhibitor, in Patients With Advanced Solid …
- Study of Tarloxotinib in Pts With NSCLC (EGFR Exon 20 Insertion, HER2-activating Mutations) & Other …
- Study Evaluating Neratinib Plus Paclitaxel VS Trastuzumab Plus Paclitaxel In ErbB-2 Positive Advance…
- Maintaining ERBB Blockade in EGFR-mutated Lung Cancer
- Afatinib Monotherapy in Patients With ERBB-deregulated Metastatic Urothelial Tract Carcinoma After F…
